25.03.2025 – 08:01ARTTIC Innovation GmbHSGLT2 HYPE: New EU-funded Project Aims to Transform Hypertension TreatmentSGLT2 HYPE websitemehr
07.03.2025 – 07:31STADA Arzneimittel AG3Press Release STADA’s growth journey continues in 2024 - Significant increase in sales and profits - Growing ahead of the marketEin Dokumentmehr
20.02.2025 – 17:05Helmholtz MunichNew Knowledge Portal Adiposetissue.org Enhances Obesity and Metabolism Research with Centralized DataVisit https://www.adiposetissue.org/mehr
14.01.2025 – 11:15Helmholtz MunichSCP-Nano: A New Technology to Visualize Nanocarriers in Cells and Tissuesmehr
09.01.2025 – 11:00Bosch Healthcare Solutions GmbHVivalytic Bacterial Meningitis by Bosch: PCR rapid test for medical emergenciesmehr
19.12.2024 – 11:43RHEACELL GmbH und Co. KGRHEACELL receives EMA approval for allo-APZ2-CVU Phase 3 trial in chronic venous ulcersmehr
11.12.2024 – 14:03Helmholtz MunichMaria-Elena Torres-Padilla Honored With the Leibniz Prize 2025Read Interviewmehr
28.11.2024 – 15:22GEA Group AktiengesellschaftGEA launches Body Condition Scoring for cowsVisit GEA's press websiteEin Dokumentmehr
25.11.2024 – 13:52Helmholtz MunichInceptor Regulates Insulin Homeostasis: A New Approach for Diabetes Therapiesmehr
14.11.2024 – 14:00ARTTIC Innovation GmbHLast Call for canSERV Third Open Call FundingOpen CallEin Dokumentmehr
16.10.2024 – 14:00ARTTIC Innovation GmbHEvent Announcement: VIROFIGHT Hybrid SymposiumRegister HereEin Dokumentmehr
24.09.2024 – 12:25RHEACELL GmbH und Co. KGRHEACELL announces FDA approval for Phase 3 study in refractory, non-curable CVUmehr
17.09.2024 – 14:05ARTTIC Innovation GmbHLaunch of canSERV Call for Service Provision – "Training the Next Generation of Cancer Researchers"Challenge CallEin Dokumentmehr
09.09.2024 – 09:06Sysmex Europe SE2Fundació Puigvert validates a new tool capable of selecting the most suitable antibiotic for uncomplicated urinary tract infections within 45 minutes.Visit our website!Ein Dokumentmehr
04.09.2024 – 15:13Fördergesellschaft IZB mbH2Record financing rounds at the Munich biotech hubFind out more about the 40+ biotech start-ups at the IZBEin Dokumentmehr
03.09.2024 – 11:10Bosch Healthcare Solutions GmbHNear-patient PCR rapid test for whooping cough for Vivalytic by Bosch now available / World's first fully automated PCR test for detection of B. pertussis, B. parapertussis, B. holmesiimehr
29.08.2024 – 14:03ARTTIC Innovation GmbHcanSERV relaunches Open Call for Service ProvisionOpen CallEin Dokumentmehr
28.08.2024 – 07:34STADA Arzneimittel AGPress release: STADA continues strong growth journey in the first half of 2024Ein Dokumentmehr
18.07.2024 – 11:05Bosch Healthcare Solutions GmbHPCR rapid test for 3 important gastroenteritis pathogens for Vivalytic by Bosch now available / World’s first fully automated PCR test for detection of C. difficile, norovirus, and rotavirus at the sampling pointmehr
02.07.2024 – 14:00ARTTIC Innovation GmbHcanSERV to Accelerate Your Cancer Research - 2 Calls for Service Provision OpencanSERV Challenge Calls2 Dokumentemehr
13.06.2024 – 10:05Sysmex Europe SE4Sysmex’s PA-100 AST System Wins One of the UK’s Biggest Science PrizesVisit our website!Ein Dokumentmehr
05.06.2024 – 17:10Helmholtz MunichNew Study: Father's Diet Before Conception Influences Children's HealthNewsroommehr
28.05.2024 – 14:05ARTTIC Innovation GmbHcanSERV invites applications for "Revolutionising Cancer Patient Care"canSERV Challenge CallEin Dokumentmehr
28.05.2024 – 14:00ARTTIC Innovation GmbH3canSERV invites applications for "Revolutionising Cancer Patient Care"canSERV CallEin Dokumentmehr
21.05.2024 – 08:13Helmholtz MunichNew Study: Night-time heat significantly increases the risk of strokeNewsroommehr
14.05.2024 – 09:01ARTTIC Innovation GmbHLAST CHANCE: canSERV Second Open Call for Cancer Research Service ProvisioncanSERV Open Call Ein Dokumentmehr
23.04.2024 – 14:02ARTTIC Innovation GmbH3canSERV Initiative: EU Consortium Launches Groundbreaking Call to Accelerate Cancer ResearchcanSERV Challenge CallEin Dokumentmehr
10.04.2024 – 11:00Dr. Reddy's Laboratories SADr. Reddy's subsidiary betapharm, and Theranica launch Nerivio® in Germany to provide patients with drug-free migraine treatmentmehr
02.04.2024 – 11:10Helmholtz MunichScientists Reveal Adipocyte's Metabolic Role and Identify Treatment Targetsmehr